Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd

Shanghai Stock Exchange 600671.SS

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd Debt to Equity Ratio for the year ending December 31, 2023: 2.96

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd Debt to Equity Ratio is 2.96 for the year ending December 31, 2023, a 137.30% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd Debt to Equity Ratio for the year ending December 31, 2022 was -7.93, a -417.79% change year over year.
  • Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd Debt to Equity Ratio for the year ending December 31, 2021 was 2.50, a 59.67% change year over year.
  • Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd Debt to Equity Ratio for the year ending December 31, 2020 was 1.56, a 79.87% change year over year.
  • Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd Debt to Equity Ratio for the year ending December 31, 2019 was 0.87, a -59.11% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
Shanghai Stock Exchange: 600671.SS

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd

CEO Mr. Guojun Dang
IPO Date Aug. 23, 1993
Location China
Headquarters No. 18, Shangyang Road
Employees 380
Sector Health Care
Industries
Description

Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, together with its subsidiaries, engages in the pharmaceutical manufacturing and drug distribution businesses in China. The company produces and sells medicines and related health care products, including tablets, granules, pills, mixtures, oral liquids, syrups, eye drops, pills, soft capsules, tablets, granules, and other health foods. It is also involved in the sale of menthol and peppermint oil raw materials, Chinese medicine formulas, Chinese medicine pieces, fresh herbs, etc.; and provision of professional medical services, such as valet decoction and distribution, slicing, and powder grinding services, as well as Chinese medicine diagnosis and treatment services. In addition, the company engages in the software development, remote health management, commercial complex management, food, Internet information businesses, etc. Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd was founded in 1958 and is headquartered in Hangzhou, China.

Similar companies

600613.SS

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

USD 0.89

3.01%

600664.SS

Harbin Pharmaceutical Group Co., Ltd.

USD 0.52

4.12%

600668.SS

Zhejiang Jianfeng Group Co., Ltd.

USD 1.32

2.87%

600666.SS

Aurora Optoelectronics Co.,Ltd.

USD 0.31

6.52%

600713.SS

NanJing Pharmaceutical Company Limited

USD 0.65

2.15%

StockViz Staff

January 15, 2025

Any question? Send us an email